Stay updated on Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page shows a new revision label (v3.6.5) replacing the previous v3.6.4, indicating a minor page update. This change does not modify any study content or eligibility details.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a small update to the page's version metadata. No changes to study details, eligibility, or results are reflected in this update.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3 in the footer. This reflects a minor metadata update rather than a change to the study details.SummaryDifference0.1%

- Check61 days agoChange DetectedA new page revision (v3.6.2) was published, replacing the previous revision (v3.6.0) for the study details page.SummaryDifference0.1%

- Check75 days agoChange DetectedNew sections for user guidance were added (How to Read a Study Record, Common Questions, How to Join a Study), and a revision note (Revision: v3.6.0) was included. The recruitment status was updated to 'No longer looking for participants', indicating there is no active enrollment at this time.SummaryDifference0.6%

- Check82 days agoChange DetectedThe page now reflects a new revision label (v3.5.5), replacing the previous v3.5.4. This indicates the content has been updated to a newer version.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page.